Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of $910,046. The enterprise value is -$956,085.
Market Cap | 910,046 |
Enterprise Value | -956,085 |
Important Dates
The last earnings date was Monday, May 13, 2024, after market close.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
VRPX has 1.17 million shares outstanding.
Shares Outstanding | 1.17M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 25.72% |
Owned by Institutions (%) | 0.33% |
Float | 869,348 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
Current Ratio | 0.72 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -345.90%.
Return on Equity (ROE) | -345.90% |
Return on Assets (ROA) | -161.80% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.41M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.43% in the last 52 weeks. The beta is 1.56, so VRPX's price volatility has been higher than the market average.
Beta (1Y) | 1.56 |
52-Week Price Change | -90.43% |
50-Day Moving Average | 3.31 |
200-Day Moving Average | 5.21 |
Relative Strength Index (RSI) | 26.45 |
Average Volume (30 Days) | 80,206 |
Short Selling Information
The latest short interest is 7,941, so 0.68% of the outstanding shares have been sold short.
Short Interest | 7,941 |
Short Previous Month | 14,839 |
Short % of Shares Out | 0.68% |
Short % of Float | 0.91% |
Short Ratio (days to cover) | 0.87 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.34M |
Pretax Income | -16.89M |
Net Income | -16.89M |
EBITDA | -16.89M |
EBIT | -16.89M |
Earnings Per Share (EPS) | -$14.42 |
Balance Sheet
The company has $1.87 million in cash and no debt, giving a net cash position of $1.87 million or $1.59 per share.
Cash & Cash Equivalents | 1.87M |
Total Debt | n/a |
Net Cash | 1.87M |
Net Cash Per Share | $1.59 |
Equity / Book Value | -1.21M |
Book Value Per Share | -1.04 |
Working Capital | -1.21M |
Cash Flow
Operating Cash Flow | -15.57M |
Capital Expenditures | n/a |
Free Cash Flow | -15.57M |
FCF Per Share | -$13.30 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1,855.88% |
FCF Yield | -1,711.42% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Mar 1, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |